(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.51%.
Korro Bio's earnings in 2026 is -$106,644,000.On average, 13 Wall Street analysts forecast KRRO's earnings for 2026 to be -$81,525,594, with the lowest KRRO earnings forecast at -$102,172,422, and the highest KRRO earnings forecast at -$53,652,891. On average, 13 Wall Street analysts forecast KRRO's earnings for 2027 to be -$73,482,446, with the lowest KRRO earnings forecast at -$127,715,528, and the highest KRRO earnings forecast at -$53,652,891.
In 2028, KRRO is forecast to generate -$62,348,385 in earnings, with the lowest earnings forecast at -$74,176,024 and the highest earnings forecast at -$48,395,836.